According to a newly published market research report by 24LifeSciences, global bladder cancer market was valued at USD 2.6 billion in 2024 and is projected to reach USD 4.1 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.7% during the forecast period 2025-2031. Bladder cancer remains one of the most prevalent urological...

    Molecular Biological Reagents market was valued at US$ 10,120 million in 2024 and is projected to reach US$ 18,230 million by 2031, expanding at a robust compound annual growth rate (CAGR) of 9.0% during the forecast period. This sustained growth highlights the critical role molecular biological reagents play across healthcare, life sciences research, and biotechnology...

    Precision Medicine market continues to demonstrate strong momentum within the healthcare and life sciences landscape. Valued at USD 130,400 million in 2024, the market is projected to reach USD 256,430 million by 2031, expanding at a compound annual growth rate (CAGR) of 10.4% during the forecast period. This robust expansion highlights the growing shift toward individualized...

According to a newly published market research report by 24LifeSciences, global advanced renal cell carcinoma therapeutics market was valued at USD 3.2 billion in 2023 and is projected to reach USD 5.8 billion by 2030, growing at a compound annual growth rate (CAGR) of 7.3% during the forecast period 20242030. Advanced renal cell carcinoma therapeutics encompass targeted therapies,...

According to a newly published market research report by 24LifeSciences, global all trans retinoic acid market was valued at USD 520 million in 2025 and is projected to reach USD 780 million by 2034, growing at a compound annual growth rate (CAGR) of 4.7% during the forecast period 2026–2034. All Trans Retinoic Acid (ATRA), chemically known as tretinoin, is a derivative of vitamin A...

According to a newly published market research report by 24LifeSciences, global angiogenesis assay market was valued at USD 19.1 million in 2024 and is projected to reach USD 33.2 million by 2031, growing at a compound annual growth rate (CAGR) of 8.4% during the forecast period. Angiogenesis, the tightly regulated process by which new blood vessels form from the existing vasculature, is...

According to a newly published market research report by 24LifeSciences, global apoptosis stimulant market was valued at USD 1.85 billion in 2024 and is projected to reach USD 3.65 billion by 2030, growing at a compound annual growth rate (CAGR) of 10.2% during the forecast period 2025–2030. Apoptosis, or programmed cell death, is a fundamental biological process responsible for...

According to a newly published market research report by 24LifeSciences, global automatic time-resolved fluorescence immunoassay analyzer market was valued at USD 850 million in 2024 and is projected to reach USD 1.65 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.6% during the forecast period 2025–2032. Automatic time-resolved fluorescence immunoassay (TRFIA)...

 According to a newly published market research report by 24LifeSciences, global automatic time-resolved fluorescence immunoassay analyzer market was valued at USD 850 million in 2024 and is projected to reach USD 1.65 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.6% during the forecast period 2025–2032. Automatic...

According to a new report from Intel Market Research, the global BioMEMS market was valued at USD 3.2 billion in 2025 and is projected to reach USD 7.8 billion by 2034, growing at a robust CAGR of 10.2 % during the forecast period (2026–2034). This expansion is driven by the rising demand for portable diagnostic platforms, rapid advances in personalized medicine, and heightened...